GMO Dynamic Allocation ETF
GMOD
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Benjamin Louis Inker
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 40 Rowes Wharf Boston MA United States of America 2110
- IPO Date
- Aug 20, 2025
- Website
- gmo.com
- Similar Companies
- Business
- GMO Dynamic Allocation ETF (GMOD) is an actively managed exchange-traded fund that seeks total return by investing dynamically across global asset classes, including equities, fixed income, commodities, and currencies. The fund employs a tactical asset allocation strategy based on proprietary macroeconomic research from GMO, its investment adviser, to adjust exposures and optimize risk-adjusted returns; it offers exposure to GMO's multi-asset capabilities through a single ticker listed on the NYSE Arca. GMOD targets institutional and retail investors seeking diversified, adaptive portfolio solutions in the actively managed ETF segment of the investment management industry. Established in 2022 and domiciled in the United States with administrative operations aligned to GMO's headquarters in Boston, Massachusetts, the ETF operates primarily in U.S. markets while providing global investment exposure across developed and emerging economies. Core offerings include systematic rebalancing among GMO's signature strategies, such as value-oriented equity sleeves, currency-hedged bond positions, and commodity tilts, all integrated into a unified multi-asset framework without leverage or derivatives beyond standard ETF structures. In recent developments, GMOD expanded its asset allocation toolkit in 2024 with enhanced integration of GMO's real asset research, enabling greater tactical tilts toward commodities amid inflationary pressures; the fund also benefited from GMO's strategic partnership announcements with select distribution platforms to broaden retail access. No major acquisitions or name changes have occurred, but the ETF saw increased assets under management following GMO's 2025 reaffirmation of its dynamic allocation philosophy in response to shifting global yield curves.